arrow
返回
J

Jhanelle E. Gray

Moffitt Cancer Center

54H指数
728论文数
3.4W被引数
收录论文 98
发表时间
SUNRAY-02: a study of olomorasib combined with immunotherapy in stage II-III KRAS G12C-mutant non-small cell lung cancer after definitive therapySUNRAY-02:奥莫罗西比与免疫疗法联合治疗经根治性治疗后处于II-III期KRAS G12C突变型非小细胞肺癌的研究
err2026-10-01
err0
errOAAI
errJamie Chaft; Jay M. Lee; Suresh Senan; Joel W. Neal; Ernest Nadal; Marcelo V. Negrao; Sanjay Popat; Marina C. Garassino; Jhanelle E. Gray; Se-Hoon Lee; Julien Mazieres; Michael Thomas; Martin Benes; Hui Liu; Jian Liu; Qinli Lily Ma; Grace Segall; Tarun Puri; Yi-Long Wu
err分享
err收藏
Therapeutic evolution: Adoption of newly approved systemic therapies in resected stage IB-IIIA NSCLC in the United States治疗进展:新批准的全身性疗法在美国切除的IB-IIIA期非小细胞肺癌中的应用
err2026-08-01
err0
PREAI
errGray, Jhanelle E.; Thoele, Kelli; Richey, Madeline; Boualam, Nada; Schwed, Karen; Brechtelsbauer, Erich; Ma, Qinli; Sheffield, Kristin M.
err分享
err收藏
Optimizing Tarlatamab Delivery in Small Cell and Neuroendocrine Lung Cancer: Real-World Insights into Step-Up Dosing and Prophylactic Tocilizumab Use优化Tarlatamab在小型细胞和神经内分泌肺癌中的递送:关于逐步增加剂量和使用预防性Tocilizumab的实际情况见解
err2025-12-02
err0
PREAI
errUtsav Joshi; Faustine Ong; Daniel Meltzer; Joanna C Ma; Andreas Saltos; Alberto Chiappori; Benjamin Creelan; Bruna Pellini; Charles Lu; Eric Haura; Michael Shafique; Tawee Tanvetyanon; Syeda Saba Kareem; Pravash Budhathoki; Daniela C Bravo Solarte; Syeda Mahrukh Hussnain Naqvi; Omar Castaneda Puglianini; Sameh Gaballa; Jhanelle E Gray; Sonam Puri
err分享
err收藏
Differences in treatment decision-making for non-small cell lung cancer among patients and physicians, by race and ethnicity不同种族和族裔的患者与医师在非小细胞肺癌治疗决策方面的差异
err2025-11-01
err0
PREAI
errDwyer Orr, Lisa; Vadagam, Pratyusha; Vanderpoel, Julie; Patel, Manali Indravadan; Basu Roy, Upal; Ledezma, Blanca; Yung, Margaret; Deering, Kathleen L.; Kulbokas, Victoria; Feldman, Josh; Gray, Jhanelle E.
err分享
err收藏
First-Line Sacituzumab Govitecan Plus Pembrolizumab in Metastatic NSCLC: PD-L1 TPS <50% and ≥50% Cohorts of the EVOKE-02 Study一线Sacituzumab Govitecan联合Pembrolizumab治疗转移性NSCLC:EVOKE-02研究PD-L1 TPS <50%和≥50%队列
err2025-10-30
err0
PREAI
errMartin Reck; Jyoti D. Patel; Jhanelle E. Gray; Noemí Reguart; Manuel Cobo; José Fuentes Pradera; Enriqueta Felip; Federico Cappuzzo; Edward B. Garon; Joel W. Neal; Sabeen Mekan; Farnoush Safavi; Nelumka Fernando; Marianna Zavodovskaya; Juliane M. Jürgensmeier; Michael Chisamore; Byoung Chul Cho
err分享
err收藏
Real World Safety of Tarlatamab Step-Up Dosing in Extensive Stage Small Cell Lung Cancer广泛期小细胞肺癌中塔拉他玛单抗递增剂量的真实世界安全性
err2025-08-29
err0
PREAI
errFaustine Ong; Utsav Joshi; Daniel J. Melzer; Joanna C. Ma; Andreas Saltos; Alberto Chiappori; Benjamin Creelan; Bruna Pellini; Charles Lu; Eric Haura; Michael Shafique; Tawee Tanvetyanon; Omar A. Castaneda Puglianini; Sameh Gaballa; Syeda Mahrukh Hussnain Naqvi; Syeda Saba Kareem; Jhanelle Gray; Sonam Puri
err分享
err收藏
Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinoma肺大细胞神经内分泌癌的整合分子与临床特征分析
err2025-08-19
err0
errOAAI
errAmin H. Nassar; Chul Kim; Tolulope Adeyelu; Elias Bou Farhat; Hassan Abushukair; Mehrdad Rakaee; Kelsey Matteson; Shun-Fat Lau; Yamato Takabe; Antonio Ocejo; Fatemeh Ardeshir-Larijani; Ticiana Leal; Suresh Ramalingam; Sumaiya Alam; Jhanelle E. Gray; James Hicks; David Kaldas; Javier Baena; Maria Zurera Berjaga; Frank Aboubakar Nana; Christian Grohe; Heike Leuders; Fabrizio Citarella; Alessio Cortellini; Emanuele Claudio Mingo; Danny Pancirer; Millie Das; Timothy John Ellis-Caleo; Justin M. Cheung; Jessica J. Lin; Alexander S. Watson; D. Ross Camidge; Arthi Sridhar; Kaushal Parikh; Fionnuala Crowley; Thomas U. Marron; Vanya Aggarwal; Murtaza Ahmed; Kamya Sankar; Hassan Kawtharany; Jun Zhang; Dwight H. Owen; Mingjia Li; Misako Nagasaka; David J. Pinato; Nichola Awosika; Khaled Alhamad; Sonam Puri; Unaiza Zaman; Divya M. Gupta; Chelsea Lau; Hina Khan; Justin Liauw; Ana I. Velazquez; Tyiesha Brown; Laura Moliner; Miguel Mosteiro; Pedro Rocha; Mark Evans; Ari Vanderwalde; Andrew Elliott; Jorge Nieva; Gilberto Lopes; Patrick C. Ma; Hossein Borghaei; Matthew Lee; Lauren Young; Raid Aljumaily; Haris Mirza; David J. Kwiatkowski; Roy S. Herbst; Richard A. Flavell; Abdul Rafeh Naqash; Anne C. Chiang
err分享
err收藏
Patient, care partner, and provider voice in treatment decision-making for non-small cell lung cancer患者、照护伙伴及医护人员在非小细胞肺癌治疗决策制定中的声音
err2025-07-01
err0
PREAI
errOrr, Lisa Dwyer; Vanderpoel, Julie; Vadagam, Pratyusha; Patel, Manali Indravadan; Roy, Upal Basu; Ledezma, Blanca; Yung, Margaret; Deering, Kathleen L.; Kulbokas, Victoria; Feldman, Josh; Gray, Jhanelle E.
err分享
err收藏
Impact of Tumor Response and Response Duration on Survival Among Participants Receiving Pembrolizumab Plus Chemotherapy as First-Line Therapy for Non-Small-Cell Lung Cancer接受帕博利珠单抗联合化疗作为非小细胞肺癌一线治疗的患者中,肿瘤应答和应答持续时间对生存的影响
err2025-06-11
err0
errOAAI
errMarina C. Garassino; Ying Cheng; Delvys Rodriguez-Abreu; Silvia Novello; Julien Mazieres; Andrew G. Robinson; Steven F. Powell; Balazs Halmos; Jhanelle E. Gray; Meihua Wang; Cong Chen; Jing Yang; Fabricio Souza; Paul Schwarzenberger; Luis Paz-Ares
err分享
err收藏
EGFR mutation testing across the osimertinib clinical program奥希替尼临床项目中的EGFR突变检测
err2025-06-01
err0
PREAI
errMurat-Onana, Marie Laure; Ramalingam, Suresh S.; Janne, Pasi A.; Gray, Jhanelle E.; Ahn, Myung-Ju; John, Tom; Yatabe, Yasushi; Huang, Xiangning; Rukazenkov, Yuri; Javey, Manana; Brown, Helen; Li-Sucholeiki, Xiaocheng
err分享
err收藏
The Phase 3 KEYLYNK-006 Study of Pembrolizumab Plus Olaparib Versus Pembrolizumab Plus Pemetrexed as Maintenance Therapy for Metastatic Nonsquamous NSCLCKEYLYNK-006 III期研究:比较培美曲塞联合奥拉帕利与培美曲塞联合培美曲塞作为转移性非鳞状非小细胞肺癌维持治疗的疗效。
err2025-02-01
err3
PREAI
errGray, Jhanelle E.; Schenker, Michael; Sendur, Mehmet Ali Nahit; Leonova, Viktoriya; Kowalski, Dariusz; Kato, Terufumi; Orlova, Rashida; Yang, James Chih-Hsin; Langleben, Adrian; Pilz, Arnold; Ungureanu, Andrei; Mak, Milena Perez; De Angelis, Flavia; Aggarwal, Himani; Zimmer, Zachary; Zhao, Bin; Shamoun, Mark; Kim, Tae Min
err分享
err收藏
Pembrolizumab With or Without Maintenance Olaparib for Metastatic Squamous NSCLC That Responded to First-Line Pembrolizumab Plus ChemotherapyPembrolizumab联合或不维持Olaparib用于转移性鳞状NSCLC,对一线Pembrolizumab加化疗有反应
err2025-02-01
err1
errOAAI
errHochmair, Maximilian; Schenker, Michael; Dols, Manuel Cobo; Kim, Tae Min; Ozyilkan, Ozgur; Smagina, Maria; Leonova, Viktoriya; Kato, Terufumi; Fedenko, Alexander; De Angelis, Flavia; Rittmeyer, Achim; Gray, Jhanelle E.; Greystoke, Alastair; Aggarwal, Himani; Huang, Qinlei; Zhao, Bin; Lara-Guerra, Humberto; Nadal, Ernest
err分享
err收藏
Lung cancer research and treatment: global perspectives and strategic calls to action肺癌研究与治疗: 全球视角与战略行动呼吁
err2024-12-01
err0
PREAI
errMeyer, M. -l.; Peters, S.; Mok, T. S.; Lam, S.; Yang, P. -c.; Aggarwal, C.; Brahmer, J.; Dziadziuszko, R.; Felip, E.; Ferris, A.; Forde, P. M.; Gray, J.; Gros, L.; Halmos, B.; Herbst, R.; Jaenne, P. A.; Johnson, B. E.; Kelly, K.; Leighl, N. B.; Liu, S.; Lowy, I.; Marron, T. U.; Paz-Ares, L.; Rizvi, N.; Rudin, C. M.; Shum, E.; Stahel, R.; Trunova, N.; Bunn, P. A.; Hirsch, F. R.
err分享
err收藏
S1701, A Randomized Phase 2 Trial of Carboplatin-Paclitaxel With and Without Ramucirumab in Patients With Locally Advanced, Recurrent, or Metastatic Thymic CarcinomaS1701,卡铂-紫杉醇联合或不联合雷莫芦单抗治疗局部晚期、复发或转移性胸腺癌患者的随机2期试验
err2024-12-01
err0
errOAAI
errTsao, Anne S.; Hsieh, Ming-Hui; Koczywas, Marianna; Tu, Janet; Riess, Jonathan; Tanvetyanon, Tawee; Ma, Barbara T.; Zhao, Ying-Qi; Redman, Mary W.; Edelman, Martin J.; Gandara, David R.; Gray, Jhanelle E.; Kelly, Karen L.
err分享
err收藏
Perioperative nivolumab (NIVO) v placebo (PBO) in patients (pts) with resectable NSCLC: Clinical update from the phase III CheckMate 77T study围手术期纳武利尤单抗(NIVO)对比安慰剂(PBO)用于可切除非小细胞肺癌(NSCLC)患者:来自III期CheckMate 77T研究的临床更新
err2024-09-01
err3
PREAI
errPulla, M. Provencio; Awad, M.; Cascone, T.; Spicer, J. D.; He, J.; Lu, S.; Alexandru, A.; Watanabe, Y.; Cornelissen, R.; Koch, L. D. O.; Kuzdzal, J.; Pujol, J-L.; Hoffknecht, P.; Gray, J. E.; Erdmann, C. Coronado; Neely, J.; Devas, V.; Bhatia, S.; Tanaka, F.
err分享
err收藏
METxMET bispecific antibody davutamig (REGN5093) for MET-altered advanced non-small cell lung cancer (aNSCLC): Update from a first-in-human (FIH) studyMETxMET双特异性抗体davutamig (REGN5093)用于MET突变型晚期非小细胞肺癌(aNSCLC)的更新:源自一项首次人体(FIH)研究
err2024-09-01
err2
PREAI
errCho, B. C.; Ahn, M-J.; Kim, T. M.; Kim, S-W.; Han, J-Y.; Kim, C.; Shim, B.; Ricordel, C.; Drilon, A. E.; Pujol, J-L.; Gray, J. E.; Villaruz, L.; Blumenschein, G.; Perez, J.; Modi, D. A.; Kaul, M.; Patel, S.; Hao, Y.; Kim, E.; Magnan, H.
err分享
err收藏
err分享
err收藏